Abstract��OBJECTIVE To assess the accessibility of essential medicines in medical institutions at all levels in Liaoning province, and provide reference for the improvement of related policies. METHODS The WHO/HAI standardized approach adjusted based on China��s national conditions was adopted. The availability, median price ratio (MPR) and disease burden per capita income were used as evaluation indicators and methods. RESULTS �� Fifty-two percent (52%) of the surveyed drugs�� availability is lower than the international general standard (50%); there was a significant difference in the availability of sample drugs at all levels of medical institutions. The specific performance was primary (27.3%) <secondary(60.3%) <tertiary (62.4%). ��The overall price level of generic drugs (MPR=1.9) is slightly lower than WHO��s recommended standard(MPR=2.0); seventy-two percent(73%) of the generic drug price did not differ significantly between different levels of medical institutions(P>0.05). ��In rural and urban areas, seventy-seven percent(77%) and ninety-two percent(92%) of essential medicines each have a course of treatment cost that is less than the WHO referenced standard, respectively. CONCLUSION Under the premise that the affordability of essential medicines is good, the availability of primary medical institutions is the lowest among surveyed institutions. In order to ensure the fairness and accessibility of essential medicines, it is suggested to strengthen the supply of essential drugs for primary-level medical institutions.
WHO,HAI. Measuring medicine prices, availability, affordability and price components(2 edition). 2008:9.
[2]
LI X,ZHANG X. Investigation and analysis of availability and affordability of essential medicine in Nanjing based on WHO/HAI standard survey method. J China Pharm(�й�ҩ��),2015(30):4188-4192.
[3]
SHI L W. Study and Speculation on National Essential Medicine Policy(���һ���ҩ���ƶ��о���̽��). Beijing:Peking Union Medical College Press,2017:33-34.
[4]
JIANG M Y,LOU H X,SUN Q, et al. Price and the accessibility of essential medicines for the elderly with chronic diseases in the Asia Pacific Region. J Shandong Univ(Health Sci)(ɽ����ѧѧ��ҽѧ��),2017,55(11):80-84.
[5]
MA Y. Study on the basic drug accessibility of community health service institutions after the implementation of the basic drug system. Suzhou:Soochow University,2016.
[6]
Management Sciences for Health(MSH). The International Medical Products Price Guide. Arlington:MSH,2015 . http://mshpriceguide.org/en/home/.
[7]
MENDIS S,FUKINO K,CAMERON A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ,2007,85(4):279.
[8]
SHANG J X,GUO Z G,LIN Q M,et al. Analysis of accessibility of essential medicine in Beijing. China J Health Policy(�й����������о�),2016,9(2):52-58.
[9]
GUAN X D,XIN X X,LIU Y, et al. Study on evaluation method for the accessibility of essential medicine in China based on WHO/HAI standardized approach. J China Pharm(�й�ҩ��),2013,24(24):2216-2219.
[10]
GELDERS, SUSANNE, EWEN,et al. Price, availability and affordability. An international comparison of chronic disease medicines. Comercializao De Medicamentos, 2006:19-20.
[11]
Global Health Observatory (GHO). Price of essential medicines. Geneva:WHO,2013(2015-6-12) . http://www.who.int/gho/mdg/medicines/en/.
[12]
DONG Z H,LI D K,WU J,et al. The theory and practice of essential medicines system. Chin Pharm J(�й�ҩѧ��־),2009,44(1):1-2.
2019, Vol. 54 
